572 related articles for article (PubMed ID: 19537379)
1. Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical non-steroidal agent.
Veraldi S; De Micheli P; Schianchi R; Lunardon L
J Drugs Dermatol; 2009 Jun; 8(6):537-9. PubMed ID: 19537379
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Abramovits W; Boguniewicz M;
J Drugs Dermatol; 2006 Mar; 5(3):236-44. PubMed ID: 16573256
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.
Abramovits W; Hebert AA; Boguniewicz M; Kempers SE; Tschen E; Jarratt MT; Lucky AW; Cornelison RL; Swinyer LJ; Jones TM
J Dermatolog Treat; 2008; 19(6):327-32. PubMed ID: 18728923
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in paediatric patients.
Patrizi A; Capitanio B; Neri I; Giacomini F; Sinagra JL; Raone B; Berardesca E
Pediatr Allergy Immunol; 2008 Nov; 19(7):619-25. PubMed ID: 18298424
[TBL] [Abstract][Full Text] [Related]
5. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis.
Belloni G; Pinelli S; Veraldi S
Eur J Dermatol; 2005; 15(1):31-6. PubMed ID: 15701590
[TBL] [Abstract][Full Text] [Related]
6. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
[TBL] [Abstract][Full Text] [Related]
7. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study.
Boguniewicz M; Zeichner JA; Eichenfield LF; Hebert AA; Jarratt M; Lucky AW; Paller AS
J Pediatr; 2008 Jun; 152(6):854-9. PubMed ID: 18492531
[TBL] [Abstract][Full Text] [Related]
8. Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial.
Kaufmann R; Bieber T; Helgesen AL; Andersen BL; Luger T; Poulin Y; Al-Hafidh J; Paul C;
Allergy; 2006 Mar; 61(3):375-81. PubMed ID: 16436149
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
[TBL] [Abstract][Full Text] [Related]
10. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness study of pediatric atopic dermatitis in Asia: atopiclair vs. regular emollient (AD-ATOP).
Tang MB; Leong KF; Ou LS; Munasir Z; Parekh PR; Azmi S; Low WH; Goh A
J Drugs Dermatol; 2015 Feb; 14(2):169-75. PubMed ID: 25689812
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R
J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pruritus with topically applied opiate receptor antagonist.
Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
[TBL] [Abstract][Full Text] [Related]
14. Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis.
Aschoff R; Schwanebeck U; Bräutigam M; Meurer M
Exp Dermatol; 2009 Jan; 18(1):24-9. PubMed ID: 18637133
[TBL] [Abstract][Full Text] [Related]
15. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
Eberlein B; Eicke C; Reinhardt HW; Ring J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
[TBL] [Abstract][Full Text] [Related]
18. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: interim analysis.
Leonardi MC; Gariboldi S; Ivaldi GB; Ferrari A; Serafini F; Didier F; Mariani L; Castiglioni S; Orecchia R
Eur J Dermatol; 2008; 18(3):317-21. PubMed ID: 18474463
[TBL] [Abstract][Full Text] [Related]
20. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
